CVBF is pleased to announce a strategic leadership evolution that marks an exciting new chapter in the company's growth. Mariagrazia Felisi has been appointed as the new Chief Executive Officer, effective from the 30th of January 2026, succeeding Donato Bonifazi, who has led the organization as CEO since the 10th of January 2012. Mariagrazia brings [...]
A comprehensive analysis of paediatric Post-Authorization Studies (PAS) in the European Union has revealed significant insights into the landscape of drug research for children, highlighting both progress and areas needing improvement. The paper published on 11 December 2024 provides a detailed examination of paediatric studies registered between 2010 and 2023. Of the 2,574 Post-Authorization [...]
Donato Bonifazi, CEO of CVBF and a member of the Board of Directors of the Teddy European Network of Excellence for Paediatric Clinical Research, will participate in upcoming EnprEMA (European Network of Paediatric Research at the European Medicines Agency) meetings and working groups. Teddy is involved in several active and proposed EnprEMA working groups: [...]
Based on the E6 ICH GCP guidelines, this training provides practical insights on implementing GCP principles. In just a few modules, you'll better understand your responsibilities when conducting clinical trials.Upon completing the training and passing a short quiz, you'll receive a certificate demonstrating your up-to-date GCP knowledge.With easy online access, interactive tools, and personalized support [...]
Mariagrazia Felisi, our Clinical Projects Director & Auditor, delivered an engaging lecture titled "Exploring Contract Research Organizations" at the clinical research workshop organized by the University of Florence's Placement Office on 6 February 2024. Boasting an impressive 25 years of hands-on experience in the realm of clinical research, Mariagrazia Felisi was selected as a speaker [...]
